200 related articles for article (PubMed ID: 37282614)
21. Vogt-Koyanagi-Harada Disease and COVID.
Manni P; Saturno MC; Accorinti M
J Clin Med; 2023 Sep; 12(19):. PubMed ID: 37834885
[TBL] [Abstract][Full Text] [Related]
22. Vogt-Koyanagi-Harada Disease: The Clinical Spectrum and Management of Case Series in a Tertiary Eye Centre in Northern Part Of Malaysia.
Hasan AN; Mustapha M; Wan HAHW
Cesk Slov Oftalmol; 2024; 80(3):140-144. PubMed ID: 38413229
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors for Vogt-Koyanagi-Harada disease.
Sheu SJ; Kou HK; Chen JF
J Chin Med Assoc; 2003 Mar; 66(3):148-54. PubMed ID: 12779034
[TBL] [Abstract][Full Text] [Related]
24. Vogt-Koyanagi-Harada Disease Associated with Hepatitis B Vaccination.
Sood AB; O'Keefe G; Bui D; Jain N
Ocul Immunol Inflamm; 2019; 27(4):524-527. PubMed ID: 29953303
[No Abstract] [Full Text] [Related]
25. [A rare case of ocular scarrings in a patient with Vogt-Koyanagi-Harada disease].
Belmokhtar A; Daoudi R
Pan Afr Med J; 2017; 28():313. PubMed ID: 29721143
[TBL] [Abstract][Full Text] [Related]
26. CLINICAL FEATURES AND PROGNOSTIC VALUE OF BACILLARY LAYER DETACHMENT IN ACUTE VOGT-KOYANAGI-HARADA DISEASE.
Kwak JJ; Lee J; Byeon SH
Retina; 2023 Oct; 43(10):1700-1707. PubMed ID: 37315551
[TBL] [Abstract][Full Text] [Related]
27. The Relationship of Vogt-Koyanagi-Harada Syndrome to Ocular Hypertension and Glaucoma.
Veerappan M; Fleischman D; Ulrich JN; Stinnett SS; Jaffe GJ; Allingham RR
Ocul Immunol Inflamm; 2017 Dec; 25(6):748-752. PubMed ID: 27438521
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids.
Abu El-Asrar AM; Al Tamimi M; Hemachandran S; Al-Mezaine HS; Al-Muammar A; Kangave D
Acta Ophthalmol; 2013 Sep; 91(6):e486-93. PubMed ID: 23575246
[TBL] [Abstract][Full Text] [Related]
29. Posterior ocular manifestations following BNT162b2 mRNA COVID-19 vaccine: a case series.
Pillar S; Weinberg T; Amer R
Int Ophthalmol; 2023 May; 43(5):1677-1686. PubMed ID: 36316618
[TBL] [Abstract][Full Text] [Related]
30. The spectrum of Vogt-Koyanagi-Harada disease in Iran.
Hedayatfar A; Hosseini SM; Karimi N; Falavarjani KG; Badie N; Zameni M; Soheilian M
Int Ophthalmol; 2018 Apr; 38(2):443-449. PubMed ID: 28260142
[TBL] [Abstract][Full Text] [Related]
31. Acute phase clinical manifestations of patients with Vogt-Koyanagi-Harada disease in Southern China.
Zhang C; Wang Y; Chen Y; Zhou H; Hong Q; Yu X; Ng TK; Cen LP
BMC Ophthalmol; 2023 May; 23(1):199. PubMed ID: 37147563
[TBL] [Abstract][Full Text] [Related]
32. Vogt-Koyanagi-Harada
Campos WR; Cenachi SPF; Soares MS; Gonçalves PF; Vasconcelos-Santos DV
Ocul Immunol Inflamm; 2021 Jan; 29(1):124-127. PubMed ID: 31603703
[No Abstract] [Full Text] [Related]
33. Comparison of Clinical Features and Visual Outcome between Sympathetic Ophthalmia and Vogt-Koyanagi-Harada Disease in Chinese Patients.
Yang P; Liu S; Zhong Z; Du L; Ye Z; Zhou W; Kijlstra A
Ophthalmology; 2019 Sep; 126(9):1297-1305. PubMed ID: 30959067
[TBL] [Abstract][Full Text] [Related]
34. Incidence, Risk Factors and Surgical Outcomes of Cataract among Patients with Vogt-Koyanagi-Harada Disease.
AlBloushi AF; Alfawaz AM; AlZaid A; Alsalamah AK; Gikandi PW; Abu El-Asrar AM
Ocul Immunol Inflamm; 2021 Jan; 29(1):128-136. PubMed ID: 31638886
[No Abstract] [Full Text] [Related]
35. Tomographic features of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
Maruyama Y; Kishi S
Ophthalmic Surg Lasers Imaging; 2004; 35(3):239-42. PubMed ID: 15185793
[TBL] [Abstract][Full Text] [Related]
36. Comments on "Goyal M, Murthy SI and Annum S, Bilateral Multifocal Choroiditis following COVID-19 Vaccination".
Khochtali S; Nabi W; Khairallah M
Ocul Immunol Inflamm; 2023 May; 31(4):880. PubMed ID: 35442844
[TBL] [Abstract][Full Text] [Related]
37. [Vogt-Koyanagi-Harada syndrome: importance of rapid diagnosis and therapeutic intervention].
Bouchenaki N; Morisod L; Herbort CP
Klin Monbl Augenheilkd; 2000 May; 216(5):290-4. PubMed ID: 10863695
[TBL] [Abstract][Full Text] [Related]
38. Differences in the clinical features of two types of Vogt-Koyanagi-Harada disease: serous retinal detachment and optic disc swelling.
Okunuki Y; Tsubota K; Kezuka T; Goto H
Jpn J Ophthalmol; 2015 Mar; 59(2):103-8. PubMed ID: 25465197
[TBL] [Abstract][Full Text] [Related]
39. Changes in Central Macular Thickness and Retinal Nerve Fiber Layer Thickness in Eyes with Vogt-Koyanagi-Harada Disease: A 2-Year Follow-Up Study.
Han YS; Shin KS; Lee WH; Kim JY
Ophthalmologica; 2018; 239(2-3):143-150. PubMed ID: 29339644
[TBL] [Abstract][Full Text] [Related]
40. Bilateral retinal detachment in a patient with Vogt-Koyanagi-Harada syndrome.
McGehee BE; Chaljub G; Shah RK; Oto A; Camacho AC; Tang RA
Emerg Radiol; 2005 Nov; 11(6):366-71. PubMed ID: 16237574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
